Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KLK7 | P49862 | 2/20 | 0.49 |
| ▸ | KLK5 | Q9Y337 | 2/20 | 0.49 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.48 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.48 |
| ▸ | TLR2 | O60603 | 1/20 | 0.47 |
| ▸ | TLR1 | Q15399 | 1/20 | 0.47 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30645065 | 0.93 | KLK7 (0.50) | KLK7KLK5ABCB1MAPTKMT2A | |
| SCHEMBL29521232 | 0.93 | KLK7 (0.54) | KLK7KLK5ABCB1MAPTKMT2A | |
| SCHEMBL29628218 | 0.93 | KLK7 (0.56) | KLK7KLK5ABCB1MAPTKMT2A | |
| SCHEMBL29370367 | 0.93 | KLK7 (0.56) | KLK7KLK5ABCB1MAPTKMT2A | |
| SCHEMBL17946769 | 0.93 | KLK7 (0.56) | KLK7KLK5ABCB1MAPTKMT2A | |
| SCHEMBL16790380 | 0.91 | CA1 (0.52) | KMT2AHDAC1HDAC2 | |
| SCHEMBL17444823 | 0.89 | KLK7 (0.53) | KLK7KLK5MAPTKMT2AHDAC1 | |
| SCHEMBL20529968 | 0.88 | KLK7 (0.53) | KLK7KLK5MAPTKMT2ATLR2 | |
| SCHEMBL29942889 | 0.88 | KLK7 (0.53) | KLK7KLK5MAPTKMT2ATLR2 | |
| SCHEMBL29387849 | 0.88 | KLK7 (0.54) | KLK7KLK5MAPTKMT2AHDAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250296954-A1 | METHOD FOR PRODUCING POLYPEPTIDE COMPOUND | CHUBU UNIVERSITY EDUCATIONAL FOUNDATION (JP) | 2025-09-25 | — | — | US | disclosed |
| EP-4516799-A1 | METHOD FOR PRODUCING POLYPEPTIDE COMPOUND | Chubu University Educational Foundation (JP) | 2025-03-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250296954-A1 | METHOD FOR PRODUCING POLYPEPTIDE COMPOUND | VIP, NPR1, NPPA | KLK7 2517/4885KLK5 2678/4885ABCB1 4252/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.